Back to search

Article

NR2F2-AS1 Suppressed Trastuzumab Effects on Esophageal Cancer By Inhibiting miR-4429 and miR-425-5p Expression Through Targeting IGF1R

2021-04-20

Abstract excerpt

<h4>Aim: </h4> In this manuscript, we aimed to investigate the involvement of non-coding RNAs in mediating trastuzumab effects in EAC. <h4>Background:</h4> Scarce evidences supported that targeted drugs, like Trastuzumab, can be applied to esophageal adenocarcinoma patients (EAC). <h4>Objective:</h4> Evaluating the role and mechanism of NR2F2-AS1 in regulating Trastuzumab effects in EAC patients. <h4>Method: </h4>...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6f65c293-e704-50bc-adb2-0a765b718b83
DOI
10.21203/rs.3.rs-401449/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
NR2F2-AS1 Suppressed Trastuzumab Effects on Esophageal Cancer By Inhibiting miR-4429 and miR-425-5p Expression Through Targeting IGF1RDOI 10.21203/rs.3.rs-401449/v1
Select a neighboring publication to make it the new centre.